Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF546 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
mRNA | TNFSF10 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | PPP2R1A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | LRRFIP2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | MC3R | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | ZNF483 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | CDC25B | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | AQP3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | CTSF | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | PNMA2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |